4 active not recruiting, 4 completed. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Active not recruiting 4, Completed 4 |
Follow Stage II Breast Cancer: new trials by email Literature Review of Stage II Breast Cancer trials Research Report on Stage II Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 TX05 (trastuzumab), Herceptin (trastuzumab) - HER2-positive Breast Cancer, Early-stage Breast Cancer | Phase 3 | Completed | Tanvex BioPharma USA, Inc. | 338 | 2019-08-20 | 2022-10-26 |
| Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer TX05 (trastuzumab), Herceptin®, Paclitaxel - Breast Cancer, Breast Neoplasms | Phase 3 | Completed | Tanvex BioPharma USA, Inc. | 809 | 2018-06-28 | 2022-01-14 |
| Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer Radiation Therapy, Questionnaire Administration, Quality-of-Life Assessment - Ductal Breast Carcinoma, Invasive Breast Carcinoma | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 898 | 2018-03-12 | 2026-02-24 |
| Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Capecitabine, Carboplatin, Cisplatin - Estrogen Receptor Negative, HER2/Neu Negative | Phase 3 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 415 | 2015-10-20 | 2026-10-02 |
| MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer Breast surgery, Magnetic resonance imaging, Mammography - Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 319 | 2014-05-21 | 2026-06-26 |
| Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery fulvestrant, anastrozole - Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 1473 | 2014-02-27 | 2026-06-05 |
| Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy Axillary Lymph Node Dissection (ALND), Nodal Radiation Therapy, Axillary Radiation Therapy - Stage II Breast Cancer, Stage IIIA Breast Cancer | Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 2012 | 2014-02-24 | 2026-08-31 |
| Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Cyclophosphamide, Epirubicin Hydrochloride, Laboratory Biomarker Analysis - HER2/Neu Positive, Stage IA Breast Cancer | Phase 3 | Completed | National Cancer Institute (NCI) | 280 | 2007-07-01 | 2019-01-23 |
Breast Neoplasms (8) · Carcinoma, Ductal, Breast (2) · Carcinoma, Lobular (2) · Triple Negative Breast Neoplasms (2)
Breast Diseases (8) · Neoplasms (8) · Neoplasms by Site (8) · Skin Diseases (8) · Skin and Connective Tissue Diseases (8) · Adenocarcinoma (2) · Carcinoma (2) · Carcinoma, Ductal (2) · Neoplasms by Histologic Type (2) · Neoplasms, Ductal, Lobular, and Medullary (2) · Neoplasms, Glandular and Epithelial (2)
Trastuzumab (3) · Cyclophosphamide (2) · Epirubicin (2) · Paclitaxel (2) · Anastrozole (1) · Capecitabine (1) · Carboplatin (1) · Cisplatin (1) · Fulvestrant (1) · Magnetic Resonance Spectroscopy (1) · Mastectomy, Segmental (1) · PF-05280014 (1) · Radiotherapy (1) · Taxes (1)
Alliance for Clinical Trials in Oncology (4) · Tanvex BioPharma USA, Inc. (2) · ECOG-ACRIN Cancer Research Group (1) · National Cancer Institute (NCI) (1)
United States (6) · Puerto Rico (3) · Belarus (2) · Canada (2) · Chile (2) · Georgia (2) · Hungary (2) · India (2) · Mexico (2) · Peru (2) · Philippines (2) · Russia (2) · Ukraine (2) · South Africa (1)
Bonnie Mills, PhD (2) · Aman Buzdar (1) · Cynthia Ma, MD, PhD (1) · Ingrid Mayer (1) · Isabelle Bedrosian, MD (1) · Judy Boughey, MD (1) · Matthew Poppe, MD (1)
PMID 24239210, PMID 27520860, PMID 28045625, PMID 28453704, PMID 30193295, PMID 31833973, PMID 34092112, PMID 37887530, PMID 38236590, PMID 38236702
U10CA031946 (2), U10CA012027 (1), U10CA037447 (1), U10CA180820 (1), U24CA196172 (1)